Overcoming Curcumin's Limitations: Synthetic Derivatives in Diabetes and Cancer Management

    November 2025 in “ Applied Research ”
    Adesola Oluwaseun Adeleye, Simon Mwaringa Dena, Oluwafemi O. Oguntibeju … Chinyerum S Opuwari
    Studysummary This review examines synthetic derivatives of curcumin for treating diabetes and cancer, reporting potential pharmacokinetic improvements and enhanced biological activity, but highlights ongoing challenges with bioavailability and stability, as well as gaps in translational research.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on onlinelibrary.wiley.com →
    Discuss this study in the Community →